Drug Approval | April 08, 2026
Aurobindo Pharma wins USFDA approval for generic Xigduo XR
Immediate U.S. launch planned for dapagliflozin-metformin ER tablets; addressable market estimated at $514 millionannually
Immediate U.S. launch planned for dapagliflozin-metformin ER tablets; addressable market estimated at $514 millionannually
The NPPA has capped prices for 41 drug combinations including diabetes, cholesterol, and sleep disorder treatments
This approval authorizes the company to export Ibuprofen to the Chinese markets
These three NDAs of Sitagliptin (base) and combination franchise have been approved by the USFDA earlier through the 505(b)(2) route
Zydus receives final approval from USFDA for its NDA Zituvimeta, extended-release tablets
IOL Chemicals and Pharmaceuticals’ product approved by CDE of NMPA, China
The product basket increased to 1800 medicines and 285 Surgical Equipment
The National Institute of Pharmacy and Nutrition, Hungary has issued 'Certificate of GMP Compliance of Manufacturer' for IOL Chemicals and Pharmaceuticals Limited's products.
Pantoprazole Sodium Sesquihydrate are proton pump inhibitors used in drugs to suppress the gastric acid secretion
Sitagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
Subscribe To Our Newsletter & Stay Updated
